BURLINGTON, N.C.--(BUSINESS WIRE)--LabCorp (NYSE: LH), a leading global life sciences company that is deeply integrated in guiding patient care, today announced it received an Emergency Use ...
On Friday evening, the FDA reissued an emergency use authorization (EUA) for LabCorp's COVID-19 RE-PCR Test that now allows for testing among those without any symptoms of COVID-19. The agency also ...
Quest Diagnostics ($DGX) and LabCorp ($LH), two of the biggest laboratory diagnostics outfits around, will not accept any blood samples from patients suspected of ...
BURLINGTON – Health diagnostics giant LabCorp will begin selling an at-home test for the COVID-19 virus after receiving emergency authorization from the U.S. Food and Drug Administration. Called Pixel ...
Labcorp’s at-home testing services just got a little more, well, at-home. Only a few months after launching its Labcorp OnDemand direct-to-consumer testing service, allowing individuals to order tests ...
Three women wearing white lab coats, masks, face shields and gloves stood around a table on a recent afternoon at LabCorp's Burlington headquarters, using box cutters to open packages. Inside each ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback